Clinical trial
Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for…
NCT00378755 · Korean Multiple Myeloma Working Party, Other · Unknown status
Key facts
| NCT number | NCT00378755 |
|---|---|
| Title | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM |
| Official title | Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Velcade, Thalidomide, Dexamethasone) Induction Followed by HDT With ASCT and Maintenance Treatment With Velcade for Newly Diagnosed MM |
| Lead sponsor | Korean Multiple Myeloma Working Party, Other |
| Collaborators | Janssen-Cilag Ltd. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | velcade |
| Enrollment | 62 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2008 |
| First posted | Sep 21, 2006 |
| Last update posted | Sep 22, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: